Current Research in Microbial Sciences,
Journal Year:
2024,
Volume and Issue:
7, P. 100314 - 100314
Published: Jan. 1, 2024
Glaucoma
is
the
primary
cause
of
irreversible
blindness
globally.
Different
glaucoma
subtypes
are
identified
by
their
underlying
mechanisms,
and
treatment
options
differ
its
pathogenesis.
Current
management
includes
topical
medications
to
lower
intraocular
pressure
surgical
procedures
like
trabeculoplasty
drainage
implants.
Fecal
microbiota
transplantation
(FMT)
an
almost
effective
safe
option
for
recurrent
Clostridium
difficile
infection.
The
relationship
between
bacterial
populations,
metabolites,
inflammatory
pathways
in
retinal
diseases
indicates
possible
therapeutic
strategies.
Thus,
incorporating
host
microbiota-based
therapies
could
offer
additional
patients.
Here,
we
propose
that
combining
FMT
with
standard
treatments
may
benefit
those
affected
this
condition.
Also,
potential
safety,
efficacy,
cost-effectiveness
clinical
applications
discussed.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(7), P. 3148 - 3148
Published: March 28, 2025
Oxidative
stress
(OS)
and
gut
microbiota
are
crucial
factors
influencing
human
health,
each
playing
a
significant
role
in
the
development
progression
of
chronic
diseases.
This
review
provides
comprehensive
analysis
complex
interplay
between
these
two
factors,
focusing
on
how
an
imbalance
reactive
oxygen
species
(ROS)
antioxidants
leads
to
OS,
disrupting
cellular
homeostasis
contributing
range
conditions,
including
metabolic
disorders,
cardiovascular
diseases,
neurological
cancer.
The
microbiota,
diverse
community
microorganisms
residing
gastrointestinal
tract,
is
essential
for
regulating
immune
responses,
pathways,
overall
health.
Dysbiosis,
composition,
closely
associated
with
inflammation,
dysfunction,
various
highlights
influences
influenced
by
complicating
pathophysiology
many
conditions.
Furthermore,
emerging
evidence
has
identified
extracellular
vesicles
(EVs)
as
critical
facilitators
crosstalk
OS
microbiota.
EVs
also
play
signaling
host
tissues,
modulating
processes.
function
holds
promise
targeted
therapies
aimed
at
restoring
microbial
balance
mitigating
OS.
Personalized
therapeutic
approaches,
probiotics,
antioxidants,
fecal
transplantation-based
strategies,
can
be
used
address
OS-related
diseases
improve
health
outcomes.
Nonetheless,
further
research
needed
study
molecular
mechanisms
underlying
interactions
potential
innovative
interventions
offer
novel
strategies
managing
enhancing
MedComm,
Journal Year:
2024,
Volume and Issue:
5(12)
Published: Nov. 20, 2024
Abstract
The
gut
microbiota
plays
a
critical
role
in
maintaining
human
health,
influencing
wide
range
of
physiological
processes,
including
immune
regulation,
metabolism,
and
neurological
function.
Recent
studies
have
shown
that
imbalances
composition
can
contribute
to
the
onset
progression
various
diseases,
such
as
metabolic
disorders
(e.g.,
obesity
diabetes)
neurodegenerative
conditions
Alzheimer's
Parkinson's).
These
are
often
accompanied
by
chronic
inflammation
dysregulated
responses,
which
closely
linked
specific
forms
cell
death,
pyroptosis
ferroptosis.
Pathogenic
bacteria
trigger
these
death
pathways
through
toxin
release,
while
probiotics
been
found
mitigate
effects
modulating
responses.
Despite
insights,
precise
mechanisms
influences
diseases
remain
insufficiently
understood.
This
review
consolidates
recent
findings
on
impact
immune‐mediated
inflammation‐associated
conditions.
It
also
identifies
gaps
current
research
explores
potential
advanced
technologies,
organ‐on‐chip
models
microbiome–gut–organ
axis,
for
deepening
our
understanding.
Emerging
tools,
single‐bacterium
omics
spatial
metabolomics,
discussed
their
promise
elucidating
microbiota's
disease
development.
Journal of Chemical Information and Modeling,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 23, 2025
It
has
been
proven
that
the
microbiome
in
human
bodies
can
promote
or
inhibit
treatment
effects
of
drugs
by
affecting
their
toxicities
and
activities.
Therefore,
identifying
drug-related
microbes
helps
understanding
how
exert
functions
under
influence
these
microbes.
Most
recent
methods
for
microbe
prediction
are
developed
based
on
graph
learning.
However,
those
fail
to
fully
utilize
diverse
characteristics
drug
entities
from
perspective
a
knowledge
graph,
as
well
contextual
relationships
among
multiple
meta-paths
meta-path
perspective.
Moreover,
previous
overlook
consistency
between
entity
features
derived
node
semantic
extracted
meta-paths.
To
address
limitations,
we
propose
knowledge-graph
transformer
category-sensitive
contrastive
learning-based
association
model
(KNDM).
This
learns
entities,
encodes
across
meta-paths,
integrates
feature
consistency.
First,
construct
consisting
which
aids
revealing
similarities
associations
any
two
entities.
Second,
considering
heterogeneity
an
integrate
diversity
types
various
them.
Third,
constructed
capture
embed
nodes.
A
learning
strategy
with
recursive
gating
is
proposed
specific
individual
while
fusing
Finally,
develop
node-category-sensitive
enhance
features.
Extensive
experiments
demonstrate
KNDM
outperforms
eight
state-of-the-art
drug-microbe
models,
ablation
studies
validate
effectiveness
its
key
innovations.
Additionally,
case
candidate
associated
three
drugs-curcumin,
epigallocatechin
gallate,
ciprofloxacin-further
showcase
KNDM's
capability
identify
potential
associations.
Journal of Personalized Medicine,
Journal Year:
2025,
Volume and Issue:
15(4), P. 144 - 144
Published: April 4, 2025
Background/Objectives:
Gastric
cancer
treatments
can
lead
to
significant
alterations
patients’
gastrointestinal
microbiome.
However,
differences
in
microbial
impacts
between
gastrectomy
and
endoscopic
submucosal
dissection
(ESD)
remain
underexplored.
This
study
investigates
how
these
influence
diversity
composition
patients
with
stage
I
gastric
cancer.
Methods:
Patients
pathologically
confirmed
were
recruited
from
Chung-Ang
University
Hospital
December
2016
2019.
analyzed
fecal
samples
13
(ESD:
n
=
5;
gastrectomy:
8)
before
after
treatment
using
16S
rRNA
gene
sequencing.
Microbial
indices
taxonomic
compared,
follow-up
extending
up
two
years.
Results:
In
the
total
cohort,
alpha
significantly
decreased
post-treatment
(p
<
0.05),
beta
analysis
showed
distinct
clustering
pre-
0.05).
At
genus
level,
Bacteroides
while
Lactobacillus,
Bifidobacterium,
Blautia
increases
Comparative
analyses
revealed
that
ESD
group,
remained
unchanged,
although
without
notable
changes
major
taxa.
contrast,
surgical
resection
resulted
a
reduction
0.05)
increased
abundances
of
Streptococcus
abundance
Conclusions:
Surgical
exerts
effects
on
microbiome
composition,
has
more
limited
impact.
These
findings
underscore
importance
considering
postoperative
management.
Children,
Journal Year:
2024,
Volume and Issue:
11(7), P. 871 - 871
Published: July 18, 2024
Antibiotic,
analgesic
sedative,
and
antiseizure
medications
are
among
the
most
commonly
used
in
preterm/sick
neonates,
who
at
high
risk
of
nosocomial
infections,
central
nervous
system
complications,
exposed
to
numerous
painful/stressful
procedures.
These
severe
potentially
life-threatening
complications
may
have
serious
short-
long-term
consequences
should
be
prevented
and/or
promptly
treated.
The
reported
variability
neonates
indicates
lack
adequate
neonatal
studies
regarding
their
effectiveness
safety.
Important
obstacles
contributing
inadequate
infants
include
difficulties
obtaining
parental
consent,
physicians’
unwillingness
recruit
preterm
infants,
off-label
use
many
other
scientific
ethical
concerns.
This
review
is
an
update
on
antimicrobials
(antifungals),
analgesics
(sedatives),
focusing
current
evidence
or
knowledge
gaps
pharmacokinetics,
indications,
safety,
dosage,
evidence-based
guidelines
for
optimal
neonates.
We
also
address
effects
early
antibiotic
intestinal
microbiome
its
association
with
immune-related
diseases,
obesity,
neurodevelopment
(ND).
Recommendations
empirical
treatment
emergence
pathogen
resistance
antifungals
presented.
Finally,
future
perspectives
prevention,
modification,
reversal
discussed.
Gut Microbes,
Journal Year:
2024,
Volume and Issue:
16(1)
Published: Sept. 21, 2024
Cardiometabolic
diseases
(CMDs),
encompassing
cardiovascular
and
metabolic
dysfunctions,
characterized
by
insulin
resistance,
dyslipidemia,
hepatic
steatosis,
inflammation,
have
been
identified
with
boosting
morbidity
mortality
due
to
the
dearth
of
efficacious
therapeutic
interventions.
In
recent
years,
studies
shown
that
variations
in
gut
microbiota
its
own
metabolites
can
influence
occurrence
CMDs.
Intriguingly,
composition
function
are
susceptible
exercise
patterns,
thus
affecting
inflammatory,
immune,
responses
within
host.
this
review,
we
introduce
key
mechanisms
intestinal
microecology
involved
onset
development
CMDs,
discuss
relationship
between
microecology,
then
analyze
role
beneficial
effects
on
aiming
at
elucidating
gut-heart
axis
mediated
protective
effect
building
avenues
for
application
management
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(21), P. 11589 - 11589
Published: Oct. 29, 2024
The
microbiome
is
a
singular
term
for
vast
array
of
life
forms
that
live
symbiotically
within
the
bodies
human
and
animal
hosts,
forming
commensal,
parasitic,
or
mutualistic
relationships
[...]